Maternal FGF2 levels associated with child anxiety and depression symptoms through child FGF2 levels

Beck, 1988, An inventory for measuring clinical anxiety: psychometric properties, J. Consult. Clin. Psychol., 56, 893, 10.1037/0022-006X.56.6.893 Birmaher, 1997, The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics, J. Am. Acad. Child Adolesc. Psychiatry, 36, 545, 10.1097/00004583-199704000-00018 Bland, 2007, Expression of fibroblast growth factor-2 and brain-derived neurotrophic factor mrna in the medial prefrontal cortex and hippocampus after uncontrollable or controllable stress, Neuroscience, 144, 1219, 10.1016/j.neuroscience.2006.11.026 Bryant, 2022, The association between salivary fgf2 and physiological and psychological components of the human stress response, Chronic Stress, 6, 10.1177/24705470221114787 Deng, 2019, Fibroblast growth factors in depression, Front. Pharmacol., 10, 60, 10.3389/fphar.2019.00060 Fumagalli, 2005, Prenatal stress elicits regionally selective changes in basal fgf-2 gene expression in adulthood and alters the adult response to acute or chronic stress, Neurobiol. Dis., 20, 731, 10.1016/j.nbd.2005.05.005 Fydrich, 1992, Reliability and validity of the beck anxiety inventory, J.Anxiety Disord., 6, 55, 10.1016/0887-6185(92)90026-4 Kiraly, 2017, Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome, Transl. Psychiatry, 7, 10.1038/tp.2017.31 Kline, 2016 Kolb, 2007, Brain plasticity and recovery from early cortical injury, Dev. Psychobiol., 49, 107, 10.1002/dev.20199 Kovacs, 1985, The Children's Depression, Inventory (CDI), Psychopharmacol. Bull., 21, 995 Lebowitz, 2021, Fibroblast growth factor 2 implicated in childhood anxiety and depression symptoms, J. Affect. Disord., 282, 611, 10.1016/j.jad.2020.12.055 Logan, 1993, Attention to external threat cues in anxiety states, Clin. Psychol. Rev., 13, 541, 10.1016/0272-7358(93)90045-N Molteni, 2001, Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity, Brain Res. Brain Res. Rev., 37, 249, 10.1016/S0165-0173(01)00128-X Monga, 2000, Screen for child anxiety-related emotional disorders (scared): convergent and divergent validity, Depress Anxiety, 12, 85, 10.1002/1520-6394(2000)12:2<85::AID-DA4>3.0.CO;2-2 Muthén, 1998 O'Donovan, 2009, Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2, Mol. Psychiatry, 14, 30, 10.1038/mp.2008.108 Olfson, 2022, Whole-exome DNA sequencing in childhood anxiety disorders identifies rare de novo damaging coding variants, Depress Anxiety, 10.1002/da.23251 Racine, 2021, Global prevalence of depressive and anxiety symptoms in children and adolescents during covid-19: a meta-analysis, JAMA Pediatr., 175, 1142, 10.1001/jamapediatrics.2021.2482 Reuss, 2003, Fibroblast growth factors and their receptors in the central nervous system, Cell Tissue Res., 313, 139, 10.1007/s00441-003-0756-7 Salmaso, 2016, Fibroblast growth factor 2 modulates hypothalamic pituitary axis activity and anxiety behavior through glucocorticoid receptors, Biol. Psychiatry, 80, 479, 10.1016/j.biopsych.2016.02.026 Terwisscha van Scheltinga, 2010, Fibroblast growth factors in schizophrenia, Schizophr. Bull., 36, 1157, 10.1093/schbul/sbp033 Turner, 2006, The fibroblast growth factor system and mood disorders, Biol. Psychiatry, 59, 1128, 10.1016/j.biopsych.2006.02.026 Turner, 2016, Dysregulated fibroblast growth factor (fgf) signaling in neurological and psychiatric disorders, Semin. Cell Dev. Biol., 53, 136, 10.1016/j.semcdb.2015.10.003 Wilcox, 2012